Venous thromboembolism in patients with non-Hodgkin lymphoma or chronic lymphocytic leukemia treated with lenalidomide: a systematic review

被引：3

作者：

Sorigue, Marc ^{[1
]}

Orna, Elisa ^{[1
]}

Sancho, Juan-Manuel ^{[1
]}

机构：

[1] Univ Autonoma Barcelona, Inst Recerca Josep Carreras, ICO Hosp Germans Trias & Pujol, Dept Hematol, Ctra Canyet S-N, Badalona 08916, Spain

来源：

LEUKEMIA & LYMPHOMA | 2018年 / 59卷 / 11期

关键词：

Lenalidomide; non-Hodgkin lymphoma; chronic lymphocytic leukemia; deep vein thrombosis; venous thromboembolism; systematic review; B-CELL LYMPHOMA; SINGLE-AGENT LENALIDOMIDE; ANTHRACYCLINE-BASED THERAPY; PHASE-II TRIAL; OPEN-LABEL; ELDERLY-PATIENTS; PLUS RITUXIMAB; INVESTIGATORS CHOICE; INITIAL TREATMENT; CLINICAL-TRIAL;

D O I：

10.1080/10428194.2018.1448085

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Lenalidomide has been associated with an increased risk of venous thromboembolism (VTE) in multiple myeloma. It is unclear whether patients with non-Hodgkin lymphoma (NHL) and chronic lymphocytic leukemia (CLL) are also at such risk. We conducted a systematic review of the incidence of VTE in prospective trials of lenalidomide-treated patients with NHL or CLL. Sixty-eight unique reports were assessed for inclusion. For grade >= 3 VTE, 98 events were reported in 3043 patients (60 studies) (crude incidence: 3.22% [95% confidence interval: 2.6-3.9%]). For any grade VTE, 97 events were reported in 2244 patients (46 studies) (crude incidence: 4.32% [3.5-5.2%]). Subgroup analysis showed no difference based on histological subtype or use of prophylaxis. The study is at risk of bias, largely due to insufficient data from the individual studies. Within the limitations of this systematic review, we found a low risk of VTE in patients with NHL treated with lenalidomide.

引用

页码：2602 / 2611

页数：10

共 76 条

[11] Results of a phase II study of lenalidomide and rituximab for refractory/relapsed chronic lymphocytic leukemia [J].

Chavez, Julio C. ;

Piris-Villaespesa, Miguel ;

Dalia, Samir ;

Powers, John ;

Turba, Elyce ;

Nodzon, Lisa ;

Komrokji, Rami ;

Sokol, Lubomir ;

Locke, Frederick L. ;

Lancet, Jeffrey ;

Sotomayor, Eduardo M. ;

Kharfan-Dabaja, Mohamed A. ;

Pinilla-Ibarz, Javier .

LEUKEMIA RESEARCH, 2016, 47 :78-83

[12] Single-Agent Lenalidomide in the Treatment of Previously Untreated Chronic Lymphocytic Leukemia [J].

Chen, Christine I. ;

Bergsagel, P. Leif ;

Paul, Harminder ;

Xu, Wei ;

Lau, Anthea ;

Dave, Nimisha ;

Kukreti, Vishal ;

Wei, Ellen ;

Leung-Hagesteijn, Chungyee ;

Li, Zhi Hua ;

Brandwein, Joseph ;

Pantoja, Mariela ;

Johnston, James ;

Gibson, Spencer ;

Hernandez, Tiffany ;

Spaner, David ;

Trudel, Suzanne .

JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (09) :1175-1181

[13] A phase I study of bendamustine, lenalidomide and rituximab in relapsed and refractory lymphomas [J].

Cheson, Bruce D. ;

Crawford, Jeanette .

BRITISH JOURNAL OF HAEMATOLOGY, 2015, 169 (04) :528-533

[14] Lenalidomide plus cyclophosphamide, doxorubicin, vincristine, prednisone and rituximab is safe and effective in untreated, elderly patients with diffuse large B-cell lymphoma: a phase I study by the Fondazione Italiana Linfomi [J].

Chiappella, Annalisa ;

Tucci, Alessandra ;

Castellino, Alessia ;

Pavone, Vincenzo ;

Baldi, Ileana ;

Carella, Angelo Michele ;

Orsucci, Lorella ;

Zanni, Manuela ;

Salvi, Flavia ;

Liberati, Anna Marina ;

Gaidano, Gianluca ;

Bottelli, Chiara ;

Rossini, Bernardo ;

Perticone, Sonia ;

De Masi, Pasqualina ;

Ladetto, Marco ;

Ciccone, Giovannino ;

Palumbo, Antonio ;

Rossi, Giuseppe ;

Vitolo, Umberto .

HAEMATOLOGICA, 2013, 98 (11) :1732-1738

[15] Combination of Lenalidomide and Rituximab Overcomes Rituximab Resistance in Patients with Indolent B-cell and Mantle Cell Lymphomas [J].

Chong, Elise A. ;

Ahmadi, Tahamtan ;

Aqui, Nicole A. ;

Svoboda, Jakub ;

Nasta, Sunita D. ;

Mato, Anthony R. ;

Walsh, Kristy M. ;

Schuster, Stephen J. .

CLINICAL CANCER RESEARCH, 2015, 21 (08) :1835-1842

[16] Sequential ofatumumab and lenalidomide for the treatment of relapsed and refractory chronic lymphocytic leukemia and small lymphocytic lymphoma [J].

Costa, Luciano J. ;

Fanning, Suzanne R. ;

Stephenson, Joe, Jr. ;

Afrin, Lawrence B. ;

Kistner-Griffin, Emily ;

Bentz, Tricia A. ;

Stuart, Robert K. .

LEUKEMIA & LYMPHOMA, 2015, 56 (03) :645-649

[17] A Phase 2/3 Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Lenalidomide Versus Investigator's Choice in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma [J].

Czuczman, Myron S. ;

Trneny, Marek ;

Davies, Andrew ;

Rule, Simon ;

Linton, Kim M. ;

Wagner-Johnston, Nina ;

Gascoyne, Randy D. ;

Slack, Graham W. ;

Brousset, Pierre ;

Eberhard, David A. ;

Hernandez-Ilizaliturri, Francisco J. ;

Salles, Gilles ;

Witzig, Thomas E. ;

Zinzani, Pier Luigi ;

Wright, George W. ;

Staudt, Louis M. ;

Yang, Yandan ;

Williams, P. Mickey ;

Lih, Chih-Jian ;

Russo, Jacqueline ;

Thakurta, Anjan ;

Hagner, Patrick ;

Fustier, Pierre ;

Song, Dale ;

Lewis, Ian D. .

CLINICAL CANCER RESEARCH, 2017, 23 (15) :4127-4137

[18] Venous Thromboembolism in Multiple Myeloma [J].

De Stefano, Valerio ;

Za, Tommaso ;

Rossi, Elena .

SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2014, 40 (03) :338-347

[19] Single-agent lenalidomide in relapsed/refractory mantle cell lymphoma: results from a UK phase II study suggest activity and possible gender differences [J].

Eve, Heather E. ;

Carey, Sean ;

Richardson, Sarah J. ;

Heise, Carla C. ;

Mamidipudi, Vidya ;

Shi, Tao ;

Radford, John A. ;

Auer, Rebecca L. ;

Bullard, Sheila H. ;

Rule, Simon A. J. .

BRITISH JOURNAL OF HAEMATOLOGY, 2012, 159 (02) :154-163

[20] Addition of lenalidomide to rituximab, ifosfamide, carboplatin, etoposide (RICER) in first-relapse/primary refractory diffuse large B-cell lymphoma [J].

Feldman, Tatyana ;

Mato, Anthony R. ;

Chow, Kar F. ;

Protomastro, Ewelina A. ;

Yannotti, Kara M. L. ;

Bhattacharyya, Pritish ;

Yang, Xiao ;

Donato, Michele L. ;

Rowley, Scott D. ;

Carini, Carolanne ;

Valentinetti, Marisa ;

Smith, Judith ;

Gadaleta, Gabriella ;

Bejot, Coleen ;

Stives, Susan ;

Timberg, Mary ;

Kdiry, Sabrina ;

Pecora, Andrew L. ;

Beaven, Anne W. ;

Goy, Andre .

BRITISH JOURNAL OF HAEMATOLOGY, 2014, 166 (01) :77-83

← 1 2 3 4 5 6 7 8 →